Fundraising FoxGeom Therapeutics
San Francisco, US · Founded 2015 · Delaware corporation
Find your way into Geom Therapeutics
Sign up to see every warm intro you have to Geom Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Geom Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DT
Dirk ThyeExecutive Chairman2016–2020Dirk Thye is an executive at Geom Therapeutics. He has founded and led multiple biotech companies through product development cycles resulting in regulatory approvals and investor returns, and specializes in corporate strategy and R&D development.
Board
DG
Dov GoldsteinBoard director
SP
Sejin ParkBoard director
YK
Yong-Zu KimBoard director
CC
Cooper CollinsBoard director
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 1 round · 2017
▶$4.4MraisedApr 2017 · 17 investors · BiotechnologyRule 506(b)
▶$4.4MraisedApr 2017 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yong-Zu KimDirector
- Cooper CollinsDirector
- Dov GoldsteinDirector
- Dirk ThyeExecutive Officer, Director
- Sejin ParkDirector
- Offering amount
- $4.5M
- Amount sold
- $4.4M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Geom Therapeutics raised?
- Geom Therapeutics has disclosed $4.4M raised across 1 round.
- Where is Geom Therapeutics headquartered?
- Geom Therapeutics is headquartered in San Francisco, US.